INCOME STATEMENT (Quarterly GAAP In millions $) |
(Sep 30 2023) III. Quarter |
(Jun 30 2023) II. Quarter |
(Mar 31 2023) I. Quarter |
(Dec 31 2022) IV. Quarter |
(Sep 30 2022) III. Quarter |
Revenue From Contract With Customer Including Assessed Tax |
2.14 |
0.96 |
1.23 |
|
- |
Interest Income, Operating |
1.22 |
1.70 |
1.80 |
|
- |
License And Collaboration Revenue |
0.12 |
0.16 |
0.34 |
|
4.46 |
Commercialization Revenue |
2.02 |
0.79 |
0.88 |
|
- |
Other Revenue |
- |
- |
- |
|
- |
Total Revenue |
5.49 |
3.61 |
4.25 |
0.22 |
4.46 |
Cost of Revenues |
- |
- |
- |
- |
- |
Gross
Profit |
5.49 |
3.61 |
4.25 |
0.22 |
4.46 |
Selling, Administration, Marketing |
12.25 |
13.34 |
13.87 |
13.25 |
18.92 |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research and Development Expense |
56.89 |
56.14 |
62.16 |
62.52 |
70.16 |
Restructuring, Accretion & impairment charges |
- |
- |
- |
- |
- |
Other operatinig exp. /-income |
5.97 |
5.55 |
3.24 |
0.00 |
0.00 |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Total operating costs including COS |
75.11 |
75.02 |
79.27 |
75.76 |
89.08 |
Operating income/-loss
|
-69.61 |
-71.41 |
-75.02 |
-75.54 |
-84.62 |
Other Deductions / - Income |
Interest expense |
1.40 |
1.38 |
1.34 |
- |
- |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
1.40 |
1.38 |
1.34 |
- |
- |
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal |
- |
- |
- |
- |
- |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
-1.19 |
-1.69 |
-1.61 |
-0.97 |
-0.54 |
Total costs & expenses |
75.31 |
74.72 |
79.00 |
74.79 |
88.54 |
Income /-loss before income taxes |
-69.82 |
-71.11 |
-74.75 |
-74.57 |
-84.08 |
Income taxes expenses/-benefit |
-0.02 |
0.00 |
0.02 |
0.00 |
0.01 |
Income after income taxes |
-69.80 |
-71.11 |
-74.77 |
-74.57 |
-84.09 |
Net income/-loss
of other equity |
- |
- |
- |
0.00 |
0.00 |
Income/-loss
from cont. Ops. |
-69.80 |
-71.11 |
-74.77 |
-74.57 |
-84.09 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
-69.80 |
-71.11 |
-74.77 |
-74.57 |
-84.09 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
-69.80 |
-71.11 |
-74.77 |
-74.57 |
-84.09 |
EBIT |
-68.42 |
-69.73 |
-73.41 |
-74.57 |
-84.08 |
EBITD |
-67.21 |
-68.53 |
-72.20 |
-73.32 |
-82.71 |
EBITDA |
-67.21 |
-68.53 |
-72.20 |
-73.32 |
-82.71 |